|
Thrombosis risk factors
Citations 1-10 of 52 total displayed.
|
Most recent content
(1 Jul 2009):
|
- Original Contributions
Patent Foramen Ovale, Cardiac Valve Thickening, and Antiphospholipid Antibodies as Risk Factors for Subsequent Vascular Events: The PICSS-APASS Study
- Kumar Rajamani, Seemant Chaturvedi, Zhezhen Jin, Shunichi Homma, Robin L. Brey, Barbara C. Tilley, Ralph L. Sacco, J.L.P. Thompson, J.P. Mohr, Steven R. Levine on Behalf of the PICSS-APASS Investigators
Stroke 2009;40:2337-2342; published online before print as doi:10.1161/STROKEAHA.108.539171
[Abstract]
[Full text]
|
Past content
(since Jan 2001):
|
- Articles
Patent Foramen Ovale, Cardiac Valve Thickening, and Antiphospholipid Antibodies as Risk Factors for Subsequent Vascular Events. The PICSS-APASS Study
- Kumar Rajamani, Seemant Chaturvedi, Zhezhen Jin, Shunichi Homma, Robin L. Brey, Barbara C. Tilley, Ralph L. Sacco, J. L.P. Thompson, J. P. Mohr, Steven R. Levine on Behalf of the PICSS-APASS Investigators
Stroke published June 4, 2009, doi:10.1161/STROKEAHA.108.539171
[Abstract]
- Original Contributions
Patient-Specific Decision-Making for Warfarin Therapy in Nonvalvular Atrial Fibrillation: How Will Screening With Genetics and Imaging Help? • Supplemental Appendix
- Mark H. Eckman, Lawrence K.S. Wong, Yannie O.Y. Soo, Wynnie Lam, Song Ran Yang, Steven M. Greenberg, and Jonathan Rosand
Stroke 2008;39:3308-3315; published online before print as doi:10.1161/STROKEAHA.108.523159
[Abstract]
[Full text]
- Articles
Patient-Specific Decision-Making for Warfarin Therapy in Nonvalvular Atrial Fibrillation. How Will Screening With Genetics and Imaging Help?
- Mark H. Eckman, Lawrence K.S. Wong, Yannie O.Y. Soo, Wynnie Lam, Song Ran Yang, Steven M. Greenberg, and Jonathan Rosand
Stroke published October 9, 2008, doi:10.1161/STROKEAHA.108.523159
[Abstract]
- Original Contributions
Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation
- Gregory Y.H. Lip, Deirdre Lane, Carl Van Walraven, and Robert G. Hart
Stroke 2006;37:2294-2300; published online before print as doi:10.1161/01.STR.0000236840.00467.84
[Abstract]
[Full text]
- Articles
Additive Role of Plasma von Willebrand Factor Levels to Clinical Factors for Risk Stratification of Patients With Atrial Fibrillation
- Gregory Y.H. Lip, Deirdre Lane, Carl Van Walraven, and Robert G. Hart
Stroke published August 3, 2006, doi:10.1161/01.STR.0000236840.00467.84
[Abstract]
- Original Contributions
Translating the Results of Randomized Trials into Clinical Practice: The Challenge of Warfarin Candidacy Among Hospitalized Elderly Patients With Atrial Fibrillation
- Elaine M. Hylek, James D’Antonio, Carmella Evans-Molina, Carol Shea, Lori E. Henault, and Susan Regan
Stroke 2006;37:1075-1080; published online before print as doi:10.1161/01.STR.0000209239.71702.ce
[Abstract]
[Full text]
- Articles
Translating the Results of Randomized Trials into Clinical Practice. The Challenge of Warfarin Candidacy Among Hospitalized Elderly Patients With Atrial Fibrillation
- Elaine M. Hylek, James D’Antonio, Carmella Evans-Molina, Carol Shea, Lori E. Henault, and Susan Regan
Stroke published March 9, 2006, doi:10.1161/01.STR.0000209239.71702.ce
[Abstract]
- Progress Reviews
Thyroid Diseases and Cerebrovascular Disease
- A. Squizzato, V.E.A. Gerdes, D.P.M. Brandjes, H.R. Büller, and J. Stam
Stroke 2005;36:2302-2310; published online before print as doi:10.1161/01.STR.0000181772.78492.07
[Abstract]
[Full text]
- Articles
Thyroid Diseases and Cerebrovascular Disease
- A. Squizzato, V. E.A. Gerdes, D. P.M. Brandjes, H. R. Büller, and J. Stam
Stroke published September 22, 2005, doi:10.1161/01.STR.0000181772.78492.07
[Abstract]
|
|
